The U.S. Food and Drug Administration (FDA) has approved it to improve wakefulness in adults with EDS associated with ...

The US District Court for the District of Columbia has upheld the decision by the US Food and Drug Administration (FDA) to keep Avadel Pharmaceutical’s narcolepsy drug, Lumryz (sodium oxybate ...

For more comprehensive information about these two drugs, you can refer to our Provigil and Adderall articles. Adderall is FDA approved to treat narcolepsy in children ages 6 years and older.

The FDA approved the oral medication July 29 ... Wakix (pitolisant) for pediatric narcolepsy: Originally approved in 2019 for adults, the non-controlled substance's June 24 approval extended ...

People who live with narcolepsy — about ... GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. In order to bring it ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

The FDA for Symbravo was based on data ... Axsome’s second marketed drug, Sunosi, is approved for treating narcolepsy. The company acquired U.S. rights to Sunosi from Jazz Pharmaceuticals ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.